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Abstract
Background: A spot-on spinetoram formulation (Cheristin®) was developed to eliminate fleas from infested cats.
This paper describes three spinetoram studies: two for registration (Studies 1 and 2), and one comparing residual
speed of kill (SOK) with topically applied fipronil/(S)-methoprene (FSM) and imidacloprid (Study 3).
Methods: Cats were randomized to treatment based on flea counts from infestations placed within 2 weeks prior
to treatment. In Studies 1 and 2, groups were untreated control and spinetoram; in Study 3, groups were untreated
control, spinetoram, FSM and imidacloprid, all applied per label on Day 0. Cats were infested the day before treatment.
In Studies 1 and 2, counts were completed 48 h post-treatment and after weekly challenges through 5 weeks. In Study
3, infestations were completed weekly through Day 28, with counts 1, 4, 8 and 12 h after treatment or post-infestation
(PI). Efficacy was determined on geometric mean flea count reductions compared with controls, and in Study 3 mean
flea counts in spinetoram-groups were compared with those in FSM and imidacloprid groups.
Results: In Studies 1 and 2, spinetoram effectiveness was 100% against existing infestations, and at least 96% through
Day 37. In Study 3 mean counts were not significantly different from controls in any group until 8 h post-treatment
when imidacloprid counts were significantly lower than spinetoram counts, which were in turn significantly lower than
FSM counts (P < 0.05). At 1 h PI spinetoram-group counts were significantly lower (P < 0.05) than counts in: controls, all
days; imidacloprid, Days 7, 14, and 28; FSM, Days 14 and 28. At 4 h PI, spinetoram mean counts were significantly lower
(P < 0.05) relative to: controls, all days; imidacloprid, Days 7, 14 and 21; FSM, Days 7, 14, 21 and 28 (P < 0.05). On multiple
occasions, at 8 and 12 h PI, mean counts were significantly lower (P < 0.05) for spinetoram than for imidacloprid and FSM;
at no point were FSM or imidacloprid significantly more effective than spinetoram against new infestations. All treatments
were well tolerated.
Conclusions: Spinetoram was highly effective for at least 1 month post-treatment and provided more rapid month-long
residual SOK than FSM or imidacloprid.
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Background
The spinosyns are a family of insecticidal fermentation
products, derived from the actinomycete, Saccharopoly-
spora spinosa. These compounds exert their selective
activity against insects primarily by allosterically activating
nicotinic acetylcholine receptors (nAChRs), binding at
receptor sites distinct from those at which other insecti-
cides exert their activity. Some activity is also provided by
spinosyns binding to γ-amino-butyric acid (GABA) recep-
tors with an overall effect that leads to rapid insect paralysis
and death [1–3]. The first of these compounds to be used
to treat ectoparasitic infestations of animals was spinosad,
which in different countries has approvals for use in or on
cattle, sheep, dogs and cats, and also as a head lice treat-
ment for humans.
The large and complex chemical structure of the
spinosyns presented opportunities for modifications to
enhance their chemical properties and biological activity.
The outcome of the application of artificial neural networks
to quantitative structure activity relationships was the
discovery of spinetoram, a mixture of major (3’-ethoxy-
5,6-dihydro spinetoram J) and minor (3’-ethoxy spine-
toram L) components. Testing in agriculture systems
demonstrated that spinetoram maintained the exceptional
environmental and toxicological profile already established
for the spinosyn class of chemistry [4]. Like spinosad some
years beforehand, spinetoram received the United
States Presidential Green Chemistry award for 2008
(Environmental Protection Agency).
Anecdotal reports of the unreliable effectiveness of
common topically applied products for cats were substan-
tiated in a study in which three consecutive monthly treat-
ments of client-owned cats with fipronil produced only a
46.1% reduction from baseline in geometric mean flea
counts. In that study, an early formulation of spinetoram
administered according to the same schedule produced
geometric mean flea count reductions of 99.4% [5].
Although that 39.6% w/v formulation of spinetoram was
non-irritant, some field reports were received of focal hair
loss from the application site in a small percentage of
treated cats. This problem was attributed to the high
viscosity of the formulation and so a formulation with a
lower concentration and viscosity was developed [6]. Pre-
liminary laboratory effectiveness studies were completed,
and tolerability studies in client-owned cats demonstrated
the acceptability and safety of an 11.2% formulation
(unpublished observations).
This report describes three studies undertaken to
determine the effectiveness of this 11.2% spinetoram
spot-on formulation (Cheristin®, Elanco, Greenfield, IN)
against fleas on cats. Two studies (Studies 1 and 2) deter-
mined effectiveness when flea (Ctenocephalides felis) counts
were completed at 48 h post-treatment, and at 48 h post-
infestations applied over the 5 weeks after treatment. Study
3 focused on the residual speed of kill of spinetoram com-
pared with that provided by imidacloprid (Advantage® II,
Bayer Animal Health, Overland Park, KS) and by fipronil/
(S)-methoprene (Frontline® Plus, Merial, Atlanta, GA).
Methods
Design of studies
All studies were controlled and utilized a blinded, ran-
domized complete block design with pre-treatment live
flea counts as a blocking factor. All protocols were ap-
proved by the relevant Institutional Animal Care and Use
Committees. Uniquely identified domestic short-hair/cross
bred cats, at least 7 months of age and weighing between
2.2 and 6.6 kg were acclimated in the trial facility for at least
14 days before the study began, and throughout each study
cats were maintained in separate individual cages. Pre-
treatment flea challenges (approximately 100 fleas per cat)
and subsequent flea comb counts 48 h post-challenge were
made at least once in each study, from 9 days to 7 days
prior to treatment. These counts were used to verify that
cats selected for the study would carry a burden of at least
30 adult fleas.
Cats meeting the inclusion/exclusion criteria with the
highest counts were rank-ordered from highest to lowest.
Blocks were formed by assigning the appropriate number
of cats, based on the number of treatment groups, with
the highest C. felis counts to the first block, the same
number of cats with the next highest counts to the second
block, and so on until the protocol-designated number of
blocks was defined. Treatments were randomly assigned
to cats within each block. Cats were housed individually
in indoor stainless-steel cages. Treated cats were not
housed over control cats, or over other treatment group
cats where banks of cages (top/bottom arrangement) were
used. In all three studies, the primary objective was the
percent reduction in geometric mean live flea counts in
treated groups when compared with counts from un-
treated or sham-treated control cats.
Treatments and groups
In all studies, treatments were administered once, on
Day 0. In Studies 1 and 2 there were 8 cats per group,
and in Study 3 six cats per group for each assessment
point.
In Studies 1 and 2 cats were randomized among two
treatment groups: Group 1: sham-treated topically with
product vehicle without active ingredient (negative con-
trol); and Group 2: treated topically with the spinetoram
11.2% formulation (Cheristin).
In Study 3, 96 cats were randomized among four treat-
ment groups, with three groups to receive commercially
available formulations of topically applied products, all
administered according to label: Group 1: Spinetoram
11.2% (Cheristin; Elanco); Group 2: Fipronil 9.8% w/v
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and (S)-methoprene 11.8% w/v (Frontline Plus for Cats);
Group 3: Imidacloprid 9.1% w/v and pyriproxyfen 0.46%
(Advantage II); Group 4: Untreated control.
Each treatment group was subdivided into 4 sub-
groups, each of six cats, formed by ranking on the basis
of Day -7 flea counts and randomizing to times of flea
counts following treatment and after each subsequent
flea infestation.
Flea infestations and counts
In all studies flea infestations were completed on
Day -1, and then at weekly intervals from Days 7 to
28. In Studies 1 and 2 an additional infestation was
completed on Day 35.
In Studies 1 and 2, flea counts were completed 48 h
post-treatment and 48 h after each subsequent infest-
ation. In Study 3, flea counts were completed 1, 4, 8
and 12 h after treatment and after each post-treatment
infestation on Days 7, 14, 21 and 28. In all 3 studies,
fleas removed during each flea count time point were
not put back onto the cats. The effectiveness calcula-
tion for each product was based on reductions in mean
live flea counts at 1, 4, 8 and 12 h after treatment or
after subsequent infestations compared to mean live
flea counts in untreated control cats infested according
to the same schedule.
All flea infestations were completed using each facility’s
in-house flea colonies which are periodically refreshed by
the introduction of locally caught fleas. The infestation
procedure involved placement of approximately 100 un-
fed, adult cat fleas onto each cat’s dorsum from the nuchal
crest or shoulder area to the lumbar-sacral region, with
the cat gently restrained in a standing or sternal recum-
bency position. Post-treatment infestations were made to
avoid placing fleas near the area of highest insecticidal
concentration. Live flea counts on each cat were obtained
by thorough combing using a metal flea comb for a
minimum of 5 min. If no fleas were found in this time,
an additional 10 strokes of the flea comb were performed
over each area of the body - dorsal, ventral, legs and
thorax. If a flea was recovered, the 10-stroke routine was
repeated until no fleas were recovered in any area. Care
was taken to avoid the site of test substance application
during the first 24 h after treatment. Combs were cleaned
with alcohol after each use, and combs used for cats in the
same treatment group were not used on cats in other
treatment groups.
Efficacy assessments
Geometric mean counts were used to assess the primary
objective of reductions in flea counts when treated
groups were compared to controls. Percent efficacy at
each time point was calculated using the formula:
% Efficacy ¼ ðMean control counts
– Mean treated cat countsÞ
 100= Mean control counts
Logarithmic transformation of flea counts was per-
formed using the logarithm of flea count + 1 to account
for zero values. Geometric mean values were obtained via
back-transformation of transformed mean counts and
subtracting one. Arithmetic means were also calculated.
For each time point, repeated measures analysis of vari-
ance was generated. The model included treatment group,
study day and treatment group by study day interaction as
fixed effects and case id as a random effect. The percent
reduction compared to control was obtained from the
least squares means of each model. Pairwise comparisons
between all treatment groups was also obtained from
these models. Primary objective assessments were based
on geometric mean count reductions.
Results
All treatments were well tolerated in each study and,
other than for occasional mild and transient cosmetic
changes typical of products applied topically to cats
(e.g. hair clumping), there were no treatment-related
adverse events. Post-treatment application-site observa-
tions indicated that any wetness and/or hair clumping in
spinetoram-treated cats on the day of, or the day after
treatment had disappeared during the following days.
In Studies 1 and 2, when flea counts were completed
48 h post-treatment and after each subsequent infest-
ation, the percentage effectiveness was 100% against in-
festations present at the time of treatment, with at least
96% effectiveness based on geometric mean counts
maintained through Day 37 (Tables 1 and 2; Fig. 1). The
least squares mean differences between the transformed
flea counts in the treated and control groups were statis-
tically significant (P < 0.0001) for each study day.
In Study 3, the comparative speed of flea kill study, no
product demonstrated significant reductions from the
control group in mean flea counts at 1 and 4 h post-
treatment (Day 0) (Tables 3 and 4). At the 1-h post-
infestation time point only the spinetoram group showed
a significant reduction from controls on Day 7 (t-test:
t(80) = -3.03, P = 0.0033), when mean flea counts were
significantly lower than in the imidacloprid group (t-test:
t(80) = -2.06, P = 0.0428) (Table 3). At this 1-h time point
the spinetoram group also had significantly lower mean
counts than the imidacloprid group on Days 14 (t-test:
t(80) = -5.19, P < 0.0001), and 28 (t-test: t(80) = -3.64, P =
0.0005), and the fipronil/(S)-methoprene group on Days
14 (t-test: t(80) = -3.85, P = 0.0002), 21 (t-test: t(80) = -3.01,
P = 0.0035) and 28 (t-test: t(80) = -2.58, P = 0.0116). At
4 h post-infestation, spinetoram provided significantly
greater effectiveness than imidacloprid on Days 7 (t-test:
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t(80) = -2.93, P = 0.0044), 14 (t-test: t(80) = -2.10, P =
0.0388) and 21 (t-test: t(80) = -3.21, P 0.0019) and fipro-
nil/(S)-methoprene on Days 7 (t-test: t(80) = -5.83, P <
0.0001), 14 (t-test: t(80) = -6.18, P < 0.0001), 21 (t-test:
t(80) = -5.54, P < 0.0001) and 28 (t-test: t(80) = -2.76, P =
0.0072) (Table 4).
At 8 h post-treatment, only the fipronil/(S)-metho-
prene group failed to achieve significant reductions in
mean flea counts from the control group. Mean counts
in the spinetoram group were significantly lower (P <
0.05) than in the fipronil/(S)-methoprene group but
significantly higher (P < 0.05) than in the imidacloprid
group (Table 5). For all counts completed 8 h after
each infestation timepoint, mean flea burdens in the
spinetoram group were significantly lower than in the
control group (Day 7: t-test: t(80) = -5.60, P < 0.0001; Day
14: t(80) = -8.62, P < 0.0001; Day 21: t(80) = -5.58, P < 0.0001;
Day 28: t(80) = -4.36, P < 0.0001) and significantly lower
than in the fipronil/(S)-methoprene group on Days 7
(t-test: t(80) = -2.61, P = 0.0108), 14 (t-test: t(80) = -4.37,
P < 0.0001) and 28 (t-test: t(80) = -2.52, P = 0.0138).
At 12 h post-treatment and on all days post-infestation,
flea counts in all treated groups were significantly lower
than those of the control groups. At 12 h post-treatment,
mean flea counts in the imidacloprid and fipronil/(S)-
methoprene groups were significantly lower than those of
the spinetoram group (t-test: t(80) = 2.29, P = 0.0245 and
t(80) = 2.19, P = 0.0315, respectively) (Table 6). At 12 h
post-infestation mean flea counts in the spinetoram group
were significantly lower than in the imidacloprid group
on Days 7 (t-test: t(80) = -2.55, P = 0.0126) and 21 (t-test:
t(80) = -3.21, P = 0.0019), and significantly lower than
the fipronil/(S)-methoprene group on Day 21 (t-test:
t(80) = -2.49, P = 0.0148).
At no post-treatment time point was the residual speed
of kill of fipronil/(S)-methoprene or imidacloprid signifi-
cantly greater than that of spinetoram against new flea
infestations. Percent effectiveness for spinetoram was
greater than for fipronil/(S)-methoprene or imidacloprid
at multiple post-treatment timepoints.
Discussion
As a combination of two semi-synthetic spinosyns (spi-
nosyns J and L), spinetoram shares a common fermenta-
tion background and mode of action with spinosad, a
mixture of spinosyns A and D. Spinosad delivered orally to
dogs has been shown in laboratory flea infestation studies
to have a rapid onset of activity that is sustained over a
month following treatment [7–9]. This effectiveness has
translated to high levels of flea control on dogs under field
conditions in which monthly treatment with spinosad pro-
vided significant improvement in flea control and in signs
Table 1 Geometric and arithmetic mean (standard deviation) flea counts of spinetoram-treated cats and percent reduction relative
to geometric mean counts in control cats in Study 1
Day of study
2 9 16 23 30 37
Untreated Control
Arithmetic mean 87.0 (10.9) 76.4 (17.2) 77.6 (15.3) 78.0 (11.3) 59.9 (21.2) 61.3 (17.0)
Geometric mean 86.4 74.5 76.4 77.2 56.3 59.3
Spinetoram
Arithmetic mean 0 (0) 0 (0) 0 (0) 0.8 (1.2) 0.1 (0.4) 2.0 (2.5)
Geometric mean 0* 0* 0* 0.5* 0.1* 1.3*
% Reduction from Control 100 100 100 99.4 99.8 97.9
*P < 0.0001
Table 2 Geometric and arithmetic mean (standard deviation) flea counts of spinetoram-treated cats and percent reduction relative
to geometric mean counts in control cats in Study 2
Day of study
2 9 16 23 30 37
Untreated Control
Arithmetic mean 56.1 (11.1) 67.1 (15.0) 65.6 (11.8) 61 (18.8) 73.4 (18.2) 68.3 (11.3)
Geometric mean 57.0 65.5 64.7 58.1 71.2 67.4
Spinetoram
Arithmetic mean 0 (0) 0 (0) 0 (0) 0.4 (1.1) 2.1 (2.3) 7.1 (10.2)
Geometric mean 0.0* 0.0* 0.0* 0.2* 1.4* 2.7*
% Reduction from Control 100 100 100 99.7 98.1 96.0
*P < 0.0001
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of FAD, including owner-scored pruritus, when compared
with other topically applied products [5, 9–11]. Similar
findings have been reported for an oral formulation of
spinosad administered to client-owned cats [12]. The
results of the studies presented in this paper validate
the potential value that a single topical application of
0.7 ml of this spinetoram formulation can bring to flea
control in cats.
The two registration studies reported here, in which
counts were completed 48 h after treatment and after each
new infestation, demonstrated that spinetoram eliminated
virtually all (98 to 100%) fleas through the month follow-
ing treatment, with efficacy of 96.0 to 97.9% still apparent
5 weeks after treatment. However, flea egg production
may begin within 24 to 36 h of the first blood meal, with
25% of fleas having fed within 5 min of finding a feline
host and 97% within 1 h [13, 14]. Thus while the 48-h
count can demonstrate the potential value of reducing egg
output, and with repeated monthly treatments potentially
solve the long term flea infestation problem in a local en-
vironment, a faster speed of kill is desirable to accelerate
the epidemiological cure, to alleviate the irritation caused
Fig. 1 Percentage reduction in geometric mean flea counts in spinetoram-treated cats from weekly post-treatment challenge infections through
Day 42 (counts 48 h post-treatment and after each infestation). Key: dark blue, Study 1; light blue, Study 2
Table 3 Geometric and arithmetic mean (standard deviation) flea counts 1 h post-treatment (Day 0) and post-reinfestations in Study 3
Day 0 Day 7 Day 14 Day 21 Day 28
Untreated Control
Arithmetic mean 55.3 (12.7) 68.5 (9.7) 69.7 (12.6) 81.2 (7.2) 86.0 (7.2)
Geometric mean 54.2 68.0a 68.6a 80.9a 85.6b
Imidacloprid
Arithmetic mean 63.8 (11.4) 60.6 (6.0) 55.2 (13.8) 59.5 (17.4) 65.5 (9.0)b,d
Geometric mean 62.9 60.2d 53.6c 57.6a 65.0b,d
% Reduction from Control 0 11.4 21.9 28.9 24.1
Fipronil/(S)-methoprene
Arithmetic mean 70.2 (13.3) 55.3 (13.4) 45.7 (5.9) 66.3 (8.3) 57.5 (9.2)
Geometric mean 69.1 53.8 45.4a,b 65.9c 57.0b,d
% Reduction from Control 0 20.8 33.9 18.5 33.5
Spinetoram
Arithmetic mean 62.0 (17.5) 47.5 (9.8) 30.5 (14.4) 45.5 (4.3) 42.3 (9.9)
Geometric mean 60.1 46.6a,d 28.0a,c 45.3a,c 41.3b,d
% Reduction from Control 0 31.4 59.2 44.0 51.8
Note: Numbers within columns with the same superscript are significantly different: Treated group comparison with control: aP < 0.01; bP < 0.05; Spinetoram
comparison with imidacloprid or fipronil/(S)-methoprene: cP < 0.01; dP < 0.05
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by flea bites and to reduce the risk of transmission of the
cestode, Dipylidium caninum, and disease causing organ-
isms such as Bartonella henselae.
Given the excellent speed of kill that orally administered
spinosad has demonstrated in laboratory studies by killing
more than 50% of fleas infesting dogs within 1 h and
achieving 100% efficacy within 4 h of treatment, it had
been anticipated that the similarly acting spinetoram
applied topically to cats would match this rapid onset of
effectiveness [7]. In fact, none of the topical products in
this study achieved such a rapid onset of efficacy, and only
imidacloprid and spinetoram showed significant differ-
ences from control at 8 h post-treatment. It would there-
fore seem that an interval of 12 to 24 h after treatment
may be needed for topical products to achieve complete
effectiveness against flea burdens present on cats at the
time of treatment, and that systemically acting products
may have a more rapid onset of activity. Support for this is
provided in a report in which systemically acting products,
by more effectively reducing the amount of blood fleas
Table 4 Geometric and arithmetic mean (standard deviation) flea counts 4 h post-treatment (Day 0) and post-reinfestations in Study 3
Day 0 Day 7 Day 14 Day 21 Day 28
Untreated Control
Arithmetic mean 58.5 (12.5) 73.2 (6.6) 73.8 (15.0) 68.2 (14.1) 71.8 (12.1)
Geometric mean 57.2 72.9a 72.4a 67.0b 70.9c
Imidacloprid
Arithmetic mean 40.2 (11.4) 28.3 (17.4) 13.8 (6.9) 23.3 (9.3) 39.0 (14.2)
Geometric mean 38.1 24.3a,c 12.5a,d 21.2b,c 36.3c
% Reduction from Control 33.4 66.7 82.7 68.4 48.8
Fipronil/(S)-methoprene
Arithmetic mean 45.7 (6.1) 50.5 (5.5) 38.0 (14.9) 39.5 (12.5) 53.0 (13.4)
Geometric mean 45.3 50.3c 35.4a,d 38.0b,c 51.3c
% Reduction from Control 20.7 31.1 51.1 43.2 27.7
Spinetoram
Arithmetic mean 49.8 (17.5) 13.0 (7.3) 10.0 (7.9) 10.0 (4.3) 28.0 (12.2)
Geometric mean 46.5 11.4a,c 7.1a,d 9.2b,c 25.8a,c
% Reduction from Control 18.6 84.3 90.2 86.3 63.7
Note: Numbers within columns with the same superscript are significantly different: Treated group comparison with control: aP < 0.01; bP < 0.05; Spinetoram
comparison with imidacloprid or fipronil/(S)-methoprene: cP < 0.01; dP < 0.05
Table 5 Geometric and arithmetic mean (standard deviation) flea counts 8 h post-treatment (Day 0) and post-reinfestations in Study 3
Day 0 Day 7 Day 14 Day 21 Day 28
Untreated Control
Arithmetic mean 67.3 (6.7) 71.5 (9.2) 70.5 (13.4) 74.7 (11.3) 71.5 (6.1)
Geometric mean 67.1a 71.0a 69.4a 73.9a 71.3a
Imidacloprid
Arithmetic mean 11.3 (8.8) 10.3 (7.6) 8.5 (9.3) 16.5 (8.2) 29.0 (10.9)
Geometric mean 8.9a,d 8.3a 4.7a 14.4a 27.1a
% Reduction from Control 86.8 88.3 93.2 80.5 62.0
Fipronil/(S)-methoprene
Arithmetic mean 53.8 (18.8) 29.5 (16.0) 18.5 (10.9) 13.0 (6.3) 38.2 (11.8)
Geometric mean 51.0d 23.9a,d 14.6a,c 11.9a 36.6d
% Reduction from Control 24.0 66.3 78.9 83.9 48.7
Spinetoram
Arithmetic mean 26.8 (18.1) 10.5 (7.3) 3.2 (2.8) 10.5 (6.2) 19.3 (15.7)
Geometric mean 21.4a,d 8.9a,d 2.3a,c 9.4a 14.4a,d
% Reduction from Control 68.1 87.5 96.7 87.3 79.8
Note: Numbers within columns with the same superscript are significantly different: Treated group comparison with control: aP < 0.01; bP < 0.05; Spinetoram
comparison with imidacloprid or fipronil/(S)-methoprene: cP < 0.01; dP < 0.05
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consume before dying, appeared to affect fleas infesting
cats more quickly than treatments that act topically [15].
There are two possible explanations, not necessarily mu-
tually exclusive, for the speed of flea knockdown of topical
products to be quicker against new infestations than against
flea burdens already established at the time of treatment.
First, fleas that have established on the cat, having already
taken a blood meal, may be more robust and so do not suc-
cumb as quickly to contact insecticidal activity. Secondly,
topically applied products may require some amount of
time to disperse from the site of application to ensure that
fleas are exposed to lethal concentrations that will provide
a rapid residual speed of kill. Importantly, the results of this
study demonstrate that the residual speed of flea kill of spi-
netoram, applied topically, was at least equal to and at mul-
tiple times greater than that of fipronil/(S)-methoprene or
imidacloprid for at least 4 weeks following application.
Conclusions
In conclusion, the results of the three studies reported
here show that this 11.2% spot-on formulation of spine-
toram provides a high level of flea killing effectiveness
that lasts beyond 1 month, and that a rapid speed of flea
kill is maintained through at least 1 month. The rapid
month-long residual speed of kill was more sustained for
spinetoram than for fipronil/(S)-methoprene or imida-
cloprid, and demonstrates that this novel spinetoram
formulation addresses the need for rapidly acting prod-
ucts that can substantially and quickly help to reduce
irritation arising from flea bites, and break the flea life
cycle by killing fleas before egg laying can begin.
Abbreviation
SOK: Speed of kill
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Table 6 Geometric and arithmetic mean (standard deviation) flea counts 12 h post-treatment (Day 0) and post-reinfestations in
Study 3
Day 0 Day 7 Day 14 Day 21 Day 28
Untreated Control
Arithmetic mean 71.7 (16.4) 77.3 (9.2) 60.3 (10.4) 72.3 (15.7) 77.3 (10.8)
Geometric mean 70.2a 76.9a 59.6a 71.0a 76.7b
Imidacloprid
Arithmetic mean 7.2 (6.2) 10.2 (6.7) 5.8 (4.6) 7.8 (3.0) 16.8 (9.3)
Geometric mean 4.7a,d 8.6a,d 3.9a 7.4a,d 14.8b
% Reduction from Control 93.3 88.9 93.4 89.6 80.8
Fipronil/(S)-methoprene
Arithmetic mean 14.8 (19.8) 4.7 (6.6) 5.3 (9.8) 6.3 (5.6) 24.7 (11.6)
Geometric mean 5.0a,d 2.0a 2.0a 4.9a,d 21.7b
% Reduction from Control 92.9 97.4 96.6 93.1 71.7
Spinetoram
Arithmetic mean 22.5 (17.1) 3.5 (4.7) 3.2 (3.5) 1.2 (1.6) 13.3 (12.9)
Geometric mean 16.4a,d 1.8a,d 2.1a 0.8a,d 8.6b
% Reduction from Control 76.6 97.7 96.5 98.9 88.8
Note: Numbers within columns with the same superscript are significantly different: Treated group comparison with control: aP < 0.01; bP < 0.05; Spinetoram
comparison with imidacloprid or fipronil/(S)-methoprene: cP < 0.01; dP < 0.05
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